Fig. 8From: Matrine combined with cisplatin synergistically inhibited urothelial bladder cancer cells via down-regulating VEGF/PI3K/Akt signaling pathwayThe 3D structures of crystal structures of the tested proteins. The 3D crystal structure of human PI3K with an endogenous ligand (PDB-ID: 4J6I) (a), Akt2 with an endogenous ligand (PDB-ID: 2JDR) (b), Caspase-3 with an endogenous ligand (PDB-ID: 2XYH) (c) and Bcl-2 with an endogenous ligand (PDB-ID: 4IEH) (d)Back to article page